Arthritis Foundation

Based in DC

🤖

AI Overview

With $3.0M in lobbying spend across 33 quarterly filings, Arthritis Foundation is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2018 to 2025.

$3.0M
Total Spend
8
Years Active
1
Firms Hired
5
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$425K
2019$500K
2020$415K
2021$300K
2022$300K
2023$425K
2024$375K
2025$300K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Arthritis Foundation disclosed contacting in their lobbying filings.

Centers For Disease Control & Prevention (CDC)Centers For Medicare and Medicaid Services (CMS)Defense, Dept of (DOD)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESNatl Institutes of Health (NIH)SENATEVeterans Affairs, Dept of (VA)Food & Drug Administration (FDA)Labor, Dept of (DOL)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Budget/Appropriations

H.R. 3767 / S. 989 Ensuring Childrens Access to Specialty Care Act

H.R. 2999 Patients' Access to Treatments Act

H.R. 2077 Restoring the Patients Voice Act

Part B

Part D

Medicaid

S. 1347, RxCAP Act

Budget Control Act

FY18 and FY19 Appropriations for DoD

FY18 and FY19 Appropriations for HHS

FY18 and FY19 Appropriations for VA

Bipartisan Budget Act of 2015

Consolidated Appropriations Act of 2018

H.R. 3767 / S. 989 Ensuring Childrens Access to Specialty Care Act

H.R. 2999 Patients' Access to Treatments Act

H.R. 2077 Restoring the Patients Voice Act

H. R. 5343, Prescription Transparency Act of

Part B

Part D

Medicaid

S. 1347, RxCAP Act

S. 2553, Know the Lowest Price Act

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.